Core Scientific, Inc.
CORZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $511 | $502 | $640 | $544 |
| % Growth | 1.6% | -21.5% | 17.6% | – |
| Cost of Goods Sold | $390 | $379 | $632 | $306 |
| Gross Profit | $121 | $123 | $8 | $239 |
| % Margin | 23.7% | 24.6% | 1.3% | 43.9% |
| R&D Expenses | $12 | $7 | $27 | $8 |
| G&A Expenses | $110 | $94 | $213 | $0 |
| SG&A Expenses | $120 | $101 | $226 | $65 |
| Sales & Mktg Exp. | $10 | $7 | $13 | $0 |
| Other Operating Expenses | $8 | $6 | $1,865 | $0 |
| Operating Expenses | $140 | $114 | $2,118 | $72 |
| Operating Income | -$19 | $9 | -$2,110 | $167 |
| % Margin | -3.8% | 1.8% | -329.5% | 30.6% |
| Other Income/Exp. Net | -$1,295 | -$255 | -$54 | -$104 |
| Pre-Tax Income | -$1,314 | -$246 | -$2,163 | $63 |
| Tax Expense | $1 | $1 | -$17 | $16 |
| Net Income | -$1,315 | -$246 | -$2,146 | $47 |
| % Margin | -257.5% | -49.1% | -335.2% | 8.7% |
| EPS | -5.14 | -0.65 | -6.3 | 0.23 |
| % Growth | -690.8% | 89.7% | -2,839.1% | – |
| EPS Diluted | -5.14 | -0.65 | -6.3 | 0.2 |
| Weighted Avg Shares Out | 256 | 380 | 341 | 207 |
| Weighted Avg Shares Out Dil | 256 | 380 | 341 | 233 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $37 | $86 | $97 | $44 |
| Depreciation & Amortization | $120 | $96 | $226 | $33 |
| EBITDA | -$1,157 | -$63 | -$1,840 | $141 |
| % Margin | -226.6% | -12.6% | -287.4% | 25.9% |